What's new? Log in Free sign up

Medicure (MCUJF)

Company Profile

Company profile

Ticker

MCUJF

Exchange

Website

www.medicure.com

CEO

Dr. Albert David Friesen Ph.D.

Incorporated

Location

Manitoba, Canada

Fiscal year end

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co. • Mississippi Power • Alabama Power • Teva Pharmaceutical Industries Limited • Abbott Laboratories • Eli Lilly and • Bristol-Myers Squibb • Viatris ...

Former names

MID AMERICA APARTMENT COMMUNITIES INC

SEC CIK

Corporate docs

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

MCUJF stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

Condensed Consolidated Interim Financial Statements

Current report (foreign)

Medicure Announces Positive Settlement of Product Development and Supply Contracts

Material Change Report

Current report (foreign)

Condensed Consolidated Interim Financial Statements

Medicure Announces Signing of Asset Purchase Agreement with Canam Bioresearch Inc. for Acquisition of Intellectual Property

Current report (foreign)

Medicure Receives Us Fda Fast Track Designation for MC-1 for Pnpo Deficiency

Annual report (foreign)

8 Apr 24

Transcripts

View all

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Latest ownership filings

Financial summary

Financial statements Chart MCUJF financial data

Quarter (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Medicure earnings reports.

Press releases

From Benzinga Pro

Medicure Reports Financial Results For Quarter Ended September 30, 2024

WINNIPEG, MB / ACCESSWIRE / November 25, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals and

Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member

WINNIPEG, MB / ACCESSWIRE / November 18, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC:MCUJF), a company focused on the development and commercialization of pharmaceuticals and

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.